pretickt

ISRG financials

Intuitive Surgical, Inc. · end-of-day data as of Oct 16, 2026

Intuitive Surgical, Inc.
ISRG · $151B
$426.70+26.4%last 60 sessions · close Oct 16, 2026
$332.02$592.8552 weeks
Buy · 34 analystsPT $478.50 +12.1%
  • P/E vs own-16.3%
  • P/E vs sector+72.4%
  • Target upside+12.1%
  • Off 52w high-28.0%
  • Insiders-$4.78M
  • FCF yield+2.1%
  • Earnings in4d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI65
  • MA20×50—
  • Volume1.3x
  • Support-0.1%
  • Resistance+4.9%

ISRG reported revenue of $2.89B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 18.5% from a year earlier. It posted diluted EPS of $2.35, free cash flow of $948M and a net margin of 28.3%.

Valuation

  • P/E48.5x
  • P/E vs own-16.3%
  • P/E vs sector+72.4%
  • FCF yield+2.1%
  • Market cap$151B

Quarterly results

Q2 FY2026: Revenue +18.5% year over year, free cash flow 32.8% of revenue, operating margin 33.6%.

RevenueFree cash flow
Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$2.89B2.35$948M67.8%33.6%28.3%
Q1 FY2026Mar 31, 2026$2.77B2.28$809M66.1%30.9%29.6%
Q4 FY2025Dec 31, 2025$2.87B2.21$730M66.4%30.2%27.7%
Q3 FY2025Sep 30, 2025$2.51B1.95$736M66.4%30.3%28.1%
Q2 FY2025Jun 30, 2025$2.44B1.81$560M66.3%30.5%27.0%
Q1 FY2025Mar 31, 2025$2.25B1.92$465M64.7%25.7%31.0%
Q4 FY2024Dec 31, 2024$2.41B1.88$511M68.0%30.4%28.4%
Q3 FY2024Sep 30, 2024$2.04B1.56$459M67.4%28.3%27.7%
Q2 FY2024Jun 30, 2024$2.01B1.46$311M68.3%28.2%26.2%
Q1 FY2024Mar 31, 2024$1.89B1.51$23.5M65.9%24.8%28.8%
Q4 FY2023Dec 31, 2023$1.93B1.69-$207M66.2%23.3%31.4%
Q3 FY2023Sep 30, 2023$1.74B1.16$292M66.9%26.7%23.8%